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Abstract: The selective accumulation of eosino-
phils in tissue is a characteristic feature of allergic
diseases where there is a predominance of lympho-
cytes expressing a Th2 phenotype. In an attempt to
define factors determining specific eosinophil accu-
mulation in vivo, we have used a radiolabeled tech-
nique to assess the occurrence and the mechanisms
underlying 111In-eosinophil recruitment into Th1-
and Th2-predominant, delayed-type hypersensitiv-
ity (DTH) reactions. Eosinophils were purified
from the blood of IL-5 transgenic mice, labeled
with 111In and injected into nontransgenic CBA/Ca
mice. Th1- and Th2-predominant, DTH reactions
were induced in mice by immunization with meth-
ylated bovine serum albumin (MBSA) in Freund’s
complete adjuvant or with Schistosoma mansoni
eggs, respectively. In these animals, 111In-eosino-
phils were recruited in skin sites in an antigen-,
time-, and concentration-dependent manner. De-
pletion of CD41 lymphocytes abrogated 111In-eo-
sinophil recruitment in both reactions. Pretreat-
ment of animals with anti-IFN-g mAb abrogated
111In-eosinophil recruitment in MBSA-immunized
and -challenged animals, whereas anti-IL-4 inhib-
ited 111In-eosinophil recruitment in both models.
Local pretreatment with an anti-eotaxin polyclonal
antibody inhibited the MBSA and SEA reactions by
51% and 39%, respectively. These results demon-
strate that, although eosinophilia is not a feature of
Th1-predominant, DTH reactions, these reactions
produce the necessary chemoattractants and ex-
press the necessary cell adhesion molecules for
eosinophil migration. The control of the circulat-
ing levels of eosinophils appears to be a most im-
portant strategy in determining tissue eosinophilia.
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INTRODUCTION
Tissue eosinophilia is a marked characteristic of allergic dis-
eases and is often associated with organ dysfunction. For
example, in asthma, the presence of activated eosinophils in
the respiratory mucosa is associated with significant lung dys-
function, and effective anti-inflammatory therapies are usually
accompanied by resolution of pulmonary eosinophilia [1, 2].
Similarly, in atopic dermatitis, deposits of eosinophil-derived
granules have been demonstrated extensively and associated
with diseased skin, although eosinophils are not seen in his-
tological sections routinely [3]. These studies support the idea
that eosinophils play a central role in the pathophysiology of
allergic diseases and suggest that the development of strategies
aimed at inhibiting eosinophil recruitment to sites of inflam-
mation in vivo may be a relevant therapeutic approach in the
treatment of allergic diseases [4–6].
In response to an appropriate inflammatory stimulus, circu-
lating blood eosinophils interact with endothelial cells initially
and then enter the tissue. The process of eosinophil migration
is regulated tightly by the expression of cell adhesion mole-
cules (CAMs) on endothelial cells and on leukocytes. In addi-
tion, eosinophils must be activated by chemoattractant mole-
cules [e.g., chemokines, leukotriene B4 (LTB4)] acting on sev-
en-transmembrane receptors on the leukocyte surface prior to
their entry into the tissue [4, 7]. However, there are other
factors that control the accumulation of eosinophils in vivo, and
these include their release from the bone marrow and circula-
tion in blood, and survival in the tissue [4]. For example, the
pretreatment of guinea pigs with interleukin (IL)-5 increases
blood levels of primed eosinophils and facilitates the recruit-
ment of these cells in the skin [8]. Similarly, the recruitment of
eosinophils in the lungs of IL-5 transgenic mice after challenge
with the chemokine eotaxin is increased markedly compared
with nontransgenic animals [9, 10]. Finally, the importance of
survival for the accumulation of leukocytes in tissues is illus-
trated by studies demonstrating the efficacy of apoptosis-in-
ducing strategies at reducing eosinophilic inflammation in
sensitized and challenged animals [11, 12].
A marked characteristic of allergic diseases, such as asthma
and atopic dermatitis, is the predominance of cytokines with a
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Th2 phenotype secreted mainly by activated T lymphocytes
[13]. It is thought that the production of these Th2 cytokines,
and especially IL-4 and IL-5, drives the local expression of cell
adhesion molecules and chemokines necessary for eosinophil
accumulation usually seen in these diseases [4, 14]. In con-
trast, tissue eosinophilia is not usually observed in diseases or
models associated with a predominant Th1 cytokine response,
although Th1 cytokines may be expressed in allergic tissues
[15, 16]. The explanations for the lack of tissue eosinophilia in
inflammatory responses associated with a Th1 response are not
entirely known and include the lack of the local expression of
the necessary chemoattractant molecules [17] and CAMs [18,
19]. However, the possibility that the IL-5-driven blood eosin-
ophilia plays a more central role in determining tissue eosin-
ophilia has not been examined in detail. The present study was
undertaken to examine the ability of eosinophils to migrate into
sites of Th1- or Th2-predominant, delayed-type hypersensitiv-
ity (DTH) reactions. To evaluate the central role of primed
blood eosinophils for eosinophil recruitment in vivo, radiola-
beled eosinophils purified from the blood of IL-5-transgenic
mice [20, 21] were injected into nontransgenic, immunized
mice, and their recruitment was assessed into discrete sites of
cutaneous inflammation following challenge with antigen.
MATERIALS AND METHODS
Animals
Female CBA/Ca mice (18–20 g) were obtained from Harlan (Bicester, UK) and
René Rachou Reseach Institute—Fiocruz (Belo Horizonte, Brazil). CBA/Ca
mice overexpresssing the murine IL-5 gene (Tg1 mice) were a gift of Glaxo
Wellcome (Stevenage, UK) and were bred in the Bioscience Unit of the
National Heart and Lung Institute, Imperial College of Science Technology and
Medicine (London, UK).
Reagents
Methylated bovine serum albumin (MBSA), concavalin A (Con A), Dextran,
Percoll, and Freund’s complete adjuvant (FCA) were purchased from Sigma
Chemical Co. (Poole, UK); Dulbeccos’s phosphate-buffered saline (PBS; cal-
cium- and magnesium-free, pH 7.4) was from Life Technologies (Paisley, UK);
LTB4 was from Cascade (Reading, UK); and Schistosoma mansoni eggs and
antigen were kindly provided by Dr. Corrêa-Oliveira (René Rachou Research
Institute).
Purification and radiolabeling of murine
eosinophils
Eosinophils (.97% purity and viability) were purified from the blood of IL-5
transgenic mice, labeled with 111In, and injected into nontransgenic CBA/CA
mice as previously described [21, 22]. Briefly, blood was obtained by cardiac
puncture (three–four donor mice/experiment), and red cells were sedimented
using Dextran (T500, one part blood to four parts Dextran 1.25%). The
leukocyte-rich supernatant was removed, centrifuged (300 g, 7 min), and
layered onto a discontinuous, four-layer, Percoll gradient (densities: 1.070,
1.075, 1.080, and 1.085 g/ml). The gradients were centrifuged at 1500 g for 25
min at 20°C, and eosinophils and lymphocytes were collected from the 1.080/
1.085 interface. Lymphocytes were removed by using negative immunoselec-
tion with rat anti-mouse CD2 and B220 mAbs (Pharmingen, San Diego, CA).
Purified eosinophils were then labeled with 111In chelated to 2-mercaptopyri-
dine-N-oxine.
DTH reactions
A Th1-predominant, DTH reaction was prepared by immunizing animals with
MBSA in FCA, as previously described [22, 23]. Briefly, mice received two
intradermal (i.d.) injections in the abdominal skin of 50 ml MBSA (5 mg/ml)
that had been emulsified in FCA. For the elicitation of the reaction, animals
were injected i.d. with MBSA (0.1–10.0 mg/site, dissolved in PBS) 6 or 7 days
after immunization. A Th2-predominant was elicited by immunizing mice
with 1000 eggs of S. mansoni [intraperitoneally (i.p.) in 100 ml PBS], as
previously described [24]. After immunization (6 or 7 days), animals were
challenged i.d. with Schistosoma egg antigen (SEA, 0.1–10 mg/site, dissolved
in PBS).
Measurement of 111In-eosinophil recruitment in
murine skin
The purified, 111In-labeled eosinophils were injected intravenously (i.v.;
13106 cells/animal) into recipient mice that had been anesthetized previously
with a mixture of Hypnorm/Hypnovel/distilled water (1/1/4). After 10 min to
allow the circulation of the radiolabeled cells, i.d. injections of MBSA, SEA, or
LTB4 were given in 50 ml vol into the shaved dorsal skin of the immunized
mice (up to four injections/animal). 111In-labeled eosinophil accumulation was
assessed at various 4-h periods (0–4, 4–8, and 20–24 h) following the i.d.
injections. A blood sample was then obtained via cardiac puncture, the animals
were sacrificed with an overdose of sodium pentobarbitone, the dorsal skin was
removed, cleaned free of excess blood, and the sites were punched out. The
samples were counted in an automatic 5-head gamma-counter (Canberra
Packard Ltd., Pangbourne, Berks, UK). Eosinophil numbers in the skin sites
were expressed as the number 111In-eosinophils per skin site.
Pretreatment with antibodies
For the neutralization of IL-4, animals were treated with the anti-IL-4 mono-
clonal antibody (mAb) 11B11 (2 mg/mouse) i.p. 1 h prior to challenge with
antigen. For the neutralization of interferon-g (IFN-g), animals were pretreated
i.p. with the anti-IFN-g mAb R4-6A2 (1 mg/mouse) 1 h prior to challenge.
Control animals received a similar dose of rat immunoglobulin G (IgG). For the
depletion of CD41 lymphocytes, animals were pretreated with the mAb GK1-5
(1 mg/mouse, i.p.) 2 h prior to challenge. CD81 lymphocyte depletion was
carried out by pretreating animals with mAb 2–43 (2 mg/mouse, i.p.) 2 h prior
to challenge. The depletion of CD4 or CD8 was confirmed by performing
fluorescein-activated cell sorter (FACS) analysis (B&D FACScan) of the lym-
phocyte population in blood and spleen using anti-CD4 or anti-CD8 fluorescein
isothiocyanate (FITC)-labeled antibodies (Sigma). To evaluate the possible role
of eotaxin as a mediator of eosinophil recruitment, skin sites were injected with
an anti-eotaxin polyclonal antibody (20% dilution in saline) 15 min prior to the
i.v. injection of 111In-eosinophils. Control sites in the same animal received an
i.d. injection of pre-immune rabbit serum (20% dilution in saline). This dose
of anti-eotaxin polyclonal antibody has been shown previously to abrogate the
migration of eosinophils induced by 150 pmoles of eotaxin [21].
Activation of spleen lymphocytes and detection
of cytokines
Spleens were collected aseptically from naı̈ve animals and animals immunized
with FCA/MBSA or Schistosoma eggs and teased into single-cell suspension. A
pool of spleens from three animals in each group was used for each experiment.
Red blood cells were then removed by spinning the cell suspension (15 min,
800 g) over a Ficoll-Paque gradient (Pharmacia, Upsala, Sweden; 1.077). Cells
obtained at the top of the gradient were collected, washed thrice, and resus-
pended in a final solution of 3 3 106 cells/ml in RPMI containing 10% fetal
bovine serum (FBS). Cell suspension (500 ml) was added to each well of
24-well plates and incubated with buffer, SEA (1, 5, and 25 mg/ml), MBSA
(1–100 mg/ml), or Con A (5 mg/ml). Samples were collected and stored 48 or
72 h later at 270°C until the measurement of cytokines. IL-4, IL-5, IL-10 (72
h cultures), and IFN-g (48 h cultures) were measured using sandwich enzyme-
linked immunosorbent assay (ELISA) with antibody pairs purchased from
Pharmingen and according to the protocol of the supplier.
Reverse transcriptase-polymerase chain reaction
(RT-PCR) assay for measuring in vivo expression
of cytokine mRNA
To investigate the expression of cytokine/chemokine mRNA, immunized or
naive mice were challenged with specific antigen, and skin sites were removed
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1, 3, 6, and 24 h later. Total RNA was extracted from each sample by the acid
guanidinium, thiocyanate-phenol-chloroform extraction method. Total RNA (1
mg) was reverse-transcribed by the addition of 2.5 U RNAsin (Promega Corp.,
Madison, WI), 2.5 mM deoxynucleotides (dNTPs) (Boehringer Mannheim
Biochemicals, Mannheim, Germany), 0.1 M dithiothreitol (Gibco BRL Life
Technologies, Inc., Grand Island, NY), IX Moloney murine leukemia virus
RNAase H2 RT buffer (Life Technologies), 25 ng Random hexamer oligonu-
cleotides (Boehringer Mannheim), and 200 U Moloney murine leukemia virus
RNAse H2 RT (Life Technologies) in 20 ml total vol. The reaction proceeded
for 1 h at 37°C and was terminated by boiling for 5 min after the addition of
175 ml H2O. The cDNA obtained (5 mL) was used for amplification in a 30 ml
PCR reaction containing 2.5 mM dNTPs (Pharmacia), a 0.2 mM concentration
of the 39 and 59 external primers, 1.5 mM MgCl2, IX GeneAmp PCR buffer,
and 5 U Taq DNA polymerase (Promega). PCR conditions were executed as
follows: denaturation (95°C for 3 min and 94°C for 1 min), annealing (52°C for
1 min), and extension (72°C for 2 min). The number of PCR cycles is given
after each sequence below, and this was followed by a final extension of 7 min
at 72°C. PCR products and molecular weight markers were run on 6%
polyacrylamide gel and stained with silver nitrate. Computer images of gels
were obtained for semiquantitation using a densitometer. The primers (sense
and anti-sense) were selected from the published cDNA sequences [25] and




CAT-ATC (35 cycles); IFN-g, AAC-GCT-ACA-CAC-TGC-ATC-TTG-G//GAC-
TTC-AAA-GAC-TCT-GAG-G (30 cycles); and hipoxanthine phosphorybosyl
transferase, GTT-GGA-TAC-AGG-CCA-GAC-TTT-GTT-G//GAT-TCA-ACT-
TGC-GCT-CAT-CTT-AGG-C (30 cycles).
Quantitation of bone marrow eosinophils
The number of eosinophils in the bone marrow of mice was quantified from
bone marrow cell suspension of femurs as previously described [26, 27]. Left
femurs from immunized or naı̈ve mice were isolated and flushed with 5 ml
Hank’s buffered salt solution containing 0.25% BSA. Samples were spun and
cell numbers determined in a Neubauer haemocytometer after dilution of
samples in Turk’s stain. The percentage of mature eosinophils was determined
using standard morphologic criteria in cytospin preparations of bone marrow
samples.
Statistical analysis
Experiments were analyzed by using two-way analysis of variance (ANOVA) on
normally distributed data. P values were assigned using Newman-Keuls pro-
cedure and values of P , 0.05 were considered statistically significant.
Percentage inhibition was calculated subtracting background values. Results
are presented as the mean 6 SE.
RESULTS
Recruitment of 111In-labeled eosinophils in sites
of DTH reactions
The i.d. administration of SEA in animals immunized with S.
mansoni eggs induced a time- and dose-dependent recruitment
of 111In-labeled eosinophils (Figs. 1 and 2). There was no
significant 111In-eosinophil recruitment from 0–4 or 4–8 h,
but a large number of cells were recruited at the late time point
of 20–24 h (Fig. 1). In a similar manner, the i.d. administration
of MBSA in animals immunized with MBSA in FCA (MBSA/
FCA) resulted in a time- and dose-dependent recruitment of
111In-labeled eosinophils (Figs. 1 and 2). In this reaction,
111In-eosinophil recruitment was already noticeable from 4–8
h, but a significantly greater number of cells were recruited in
the 20–24 h measurement period (Fig. 1). The specificity of
both reactions was assessed by the i.d. injection of the relevant
antigen in naive, Schistosoma egg- or MBSA/FCA-immunized
animals. As clearly demonstrated in Figure 2, the sensitization
procedure imparted a great degree of specificity to the reac-
tions. A large number of 111In-eosinophils migrated to sites
injected with antigen in the relevant immunized animal but not
in naive animals or those immunized with the other irrelevant
antigen (Fig. 2). For comparison, the i.d. administration of
LTB4, an effective eosinophil chemoattractant [7, 21], induced
Fig. 1. Kinetics of the recruitment of 111In-eosinophils in Th1- and Th2-
predominant, DTH reactions. Animals that had been immunized with MBSA/
FCA (Th1) or S. mansoni eggs (Th2) received i.d. injections of antigen (MBSA,
10 mg/site; SEA, 1 mg/site) at 20 h, 4 h, and immediately before the i.v.
administration of 111In-eosinophils. LTB4 (150 pmol/site) was given immedi-
ately before the 111In-eosinophils. The number of 111In-eosinophils that mi-
grated to skin sites was assessed 4 h after their i.v. administration. Results are
the mean 6 SE of six animals in each group.
Fig. 2. Dose- and antigen-dependent recruitment of 111In-eosinophils in Th1-
and Th2-predominant, DTH reactions. Animals that were not immunized (open
bars) or that had been immunized with MBSA/FCA (Th1, hatched bars) or S.
mansoni eggs (Th2, closed bars) received i.d. injections of antigen (MBSA, 1
or 10 mg/site; SEA, 1 or 10 mg/site) 20 h before the i.v. administration of
111In-eosinophils. The effects of the i.d. injection of PBS and LTB4 (150
pmol/site) immediately before the i.v. administration of 111In-eosinophils are
shown for comparison. The number of 111In-eosinophils that migrated to skin
sites was assessed 4 h after their i.v. administration. Results are the mean 6
SE of six animals in each group.
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a similar recruitment of 111In-eosinophils in naive and immu-
nized animals, although the response was substantially smaller
(Fig. 2).
Histological studies of skin sites in naı̈ve mice
The administration of SEA to S. mansoni, egg-immunized
animals induced a marked inflammatory infiltrate at 24 h in the
injected skin sites. The majority of the migrating cells was
mononuclear, but eosinophils comprised about 20–30% of the
inflammatory infiltrate (Fig. 3, C and D). The administration
of MBSA to animals immunized with MBSA/FCA also induced
a marked mononuclear cell infiltrate in the injected skin sites
(Fig. 3, A and B). Nevertheless, and in contrast to the ability of
111In-labeled eosinophils to migrate to sites of MBSA chal-
lenge, only occasional endogenous eosinophils were noticed
(Fig. 3B).
Cytokine profile of spleen cells and challenged
tissue of immunized animals
Spleen cells were obtained from naive, S. mansoni, egg- and
MBSA/FCA-immunized animals and stimulated with Con A,
MBSA, or SEA. Con A-stimulated spleen cells from naive
animals secreted a significant amount of IFN-g and IL-10 but
not IL-5 or IL-4 (Fig. 4). Neither SEA nor MBSA induced
significant cytokine secretion from splenocytes of naive ani-
mals (Fig. 4). Upon stimulation with specific antigen (SEA) or
Con A, splenocytes from S. mansoni, egg-immunized mice
secreted significant amounts of IFN-g, IL-10, and IL-5 (Fig. 4).
Splenocytes from MBSA/FCA-immunized animals produced a
large amount of IFN-g spontaneously, but this was enhanced
further in the presence of Con A or specific antigen (MBSA;
Fig. 4). In splenocyte cultures, little IL-4, IL-5, or IL-10 was
produced in the presence of MBSA (Fig. 4).
The kinetics of the expression of mRNA for the Th2 cytokine
IL-4 and the Th1 cytokine IFN-g in skin sites of MBSA/FCA-
immunized and S. mansoni, egg-immunized and -challenged
animals are shown in Figure 5. In MBSA/FCA-immunized
animals, the challenge with specific antigen induced a signif-
icant expression of IFN-g early (from 1–6 h) in the course of
the reaction and low-level expression of IL-4 at 3 and 24 h (Fig.
5a). The challenge of egg-immunized animals with SEA in-
duced low-level expression of IFN-g from 1–6 h and high
levels of IL-4 expression from 6–24 h after challenge (Fig. 5b).
There was no detectable expression of IL-4 or IFN-g in im-
munized animals challenged with PBS, and injection of antigen
in naive animals had little effect on cytokine mRNA expression
(unpublished results).
Effects of the depletion of CD41 and CD81
cells
Pretreatment of animals with the anti-CD4 mAb GK1.3 re-
sulted in virtually complete depletion of circulating and spleen
CD41 cells in S. mansoni, egg- and MBSA/FCA-immunized
animals, as assessed by flow cytometry (unpublished results).
As seen in Figure 6, anti-CD4 treatment abrogated the re-
cruitment of 111In-eosinophils in SEA- and MBSA-induced
DTH reactions. In contrast, pretreatment with the anti-CD8
mAb R4-6A2, which depleted CD81 cells (unpublished re-
sults), had no significant effect on the numbers of infiltrating
111In-eosinophils in both reactions (Fig. 6). For comparison,
neither antibody treatment had any significant effect on LTB4-
induced, 111In-eosinophil recruitment (Fig. 6c).
Fig. 3. Histological sections of skin sites of Th1- and Th2-predominant, DTH
reactions. Animals that had been immunized with MBSA/FCA (A and B) or S.
mansoni eggs (C and D) received i.d. injections of antigen (MBSA, 10 mg/site;
SEA, 1 mg/site, respectively) 24 h prior to sacrifice. Note the marked inflam-
matory infiltrate seen in both reactions at 24 h (A and C; original size, 3100).
In greater magnification (original size, 3400), note the large number of
infiltrating eosinophils in Th2 predominant, DTH reactions (D) but not in
Th1-predominant, DTH reactions (B).
Fig. 4. Profile of the production of (a) IFN-g, (b) IL-4, (c) IL-5, and (d) IL-10
by splenocytes obtained from naı̈ve animals or animals immunized with MBSA/
FCA or S. mansoni eggs. Splenocytes from naı̈ve or immunized animals were
stimulated with vehicle (open bars), Con A (5 mg/ml, closed bars), MBSA (10
mg/ml, hatched bars), or SEA (5 mg/ml, stippled bars). Supernatants were
collected for cytokine measurements by ELISA 48 h (IL-4, IL-5, and IL-10) or
72 h (IFN-g) later. Results are representative of two similar experiments and
are the mean of triplicates from pooled cells of three mice in each group.
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Effects of the neutralization of IL-4 and IFN-g
The next series of experiments assessed whether pretreatment
with blocking antibodies against IL-4 and IFN-g would affect
the recruitment of 111In-eosinophils in sites of late-onset al-
lergic reactions. The antibodies were given after the immuni-
zation procedure and 1 h prior to challenge. As demonstrated
in Figure 7a, pretreatment with anti-IL-4, but not anti-IFN-g,
partially inhibited 111In-eosinophil recruitment into sites of
DTH reactions induced by SEA in S. mansoni, egg-immunized
animals. Surprisingly, anti-IL-4 and anti-IFN-g abrogated the
recruitment of 111In-eosinophils in sites of DTH reactions
induced by MBSA in MBSA/FCA-immunized animals (Fig.
7b). Neither antibody treatment affected the recruitment of
111In-eosinophils induced by the i.d. injection of LTB4 (Fig.
7c).
Effects of the neutralization of eotaxin
We have shown previously that the chemokine eotaxin induced
significant 111In-eosinophil recruitment in murine skin and was
released endogenously in sites of allergic inflammation [21].
When the expression of eotaxin was assessed by RT-PCR,
significant message was detected early (from 1–6 h) in the
course of both reactions (Fig. 5). Moreover and in agreement
with the significant expression of eotaxin, an anti-eotaxin poly-
clonal antibody used at a dilution (20% in PBS) previously
shown to abrogate the effects of eotaxin [21], inhibited 111In-
eosinophil recruitment in MBSA/FCA and egg/SEA DTH re-
actions (Fig. 8).
Bone marrow eosinophils in S. mansoni, egg-
and MBSA/FCA-immunized animals
The results above demonstrate that endogenous eosinophils fail
to migrate into sites of Th1 predominant, MBSA/FCA reac-
tions, whereas these cells are found in abundance in S. man-
soni, egg-immunized and SEA-challenged animals (Fig. 3). In
contrast, exogenously added 111In-eosinophils appear to mi-
grate to both reactions upon challenge with specific antigen. To
gain further insights into the mechanisms explaining the re-
cruitment of endogenous eosinophils, we evaluated the total
number of leukocytes and mature eosinophils present in the
bone marrow of MBSA/FCA and S. mansoni, egg-immunized
mice. As seen in Figure 9, immunization with S. mansoni eggs
induced a significant increase in the total number of mature
eosinophils in the bone marrow of mice, whereas MBSA/FCA
immunization enhanced the total number of cells but failed to
affect eosinophil numbers. The increase in total leukocytes in
the bone marrow of MBSA/FCA mice was explained to some
extent by an increase in the number of mature neutrophils
(unpublished results).
Fig. 6. Effects of the depletion of
CD41 or CD81 cells on the recruit-
ment of 111In-eosinophils in Th1- and
Th2-predominant, DTH reactions.
Control animals (open bars) and ani-
mals that had been immunized with (a)
MBSA/FCA (Th1) or (b) S. mansoni
eggs (Th2) were depleted of CD41
(closed bars) or CD81 (hatched bars)
cells. Skin sites were then challenged
i.d. with antigen (MBSA, 10 mg/site;
SEA, 1 mg/site, respectively) 20 h be-
fore the i.v. administration of 111In-
eosinophils. The effects of the i.d. injection of PBS and (c) LTB4 (150
pmol/site) immediately before the i.v. administration of 111In-eosinophils into
control and CD41 or CD81 cell-depleted animals are shown for comparison.
The number of 111In-eosinophils that migrated to skin sites was assessed 4 h
after their i.v. administration. Results are the mean 6 SE of six animals in each
group. *p , 0.01 when compared with control animals.
Fig. 5. Expression of mRNA for eotaxin, IL-4, and IFN-g in (a) Th1- and (b)
Th2-predominant, DTH reactions. Mice were immunized with MBSA/FCA
(Th1) or S. mansoni eggs (Th2) and challenged i.d. with the relevant antigen
(MBSA, 10 mg/site; SEA, 1 mg/site, respectively). Before (time 0) and at
various times after challenge (1, 3, 6, and 24 h), skin sites from three animals
were removed, pooled, mRNA-extracted, and reverse-transcribed using spe-
cific primers for HPRT, eotaxin, IFN-g, and IL-4. The data are representative
of two similar experiments.
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DISCUSSION
The recruitment of activated eosinophils into skin sites appears
to play a major role in the pathophysiology of allergic disorders
[1–3]. The recruitment of eosinophils to sites of inflammation
in vivo is largely dependent on the local expression of che-
moattractant molecules (e.g., chemokines and LTB4) and
CAMs [4]. Nevertheless, there is some evidence to support a
role for IL-5-driven blood eosinophilia in determining eosino-
phil recruitment in sites of inflammation [8–10, 28, 29]. In the
present study, we have investigated whether the IL-5-driven
blood eosinophilia plays a determinant role for the recruitment
of eosinophils in vivo. To evaluate this central role of primed
blood eosinophils for eosinophil recruitment in vivo, radiola-
beled eosinophils purified from the blood of IL-5 transgenic
mice were injected into nontransgenic, immunized mice, and
their recruitment was assessed into discrete sites of cutaneous
inflammation following challenge with antigen.
Two immunization procedures were used in the experiments
described herein. A set of animals was immunized with S.
mansoni egg and challenged with SEA, and another set of
animals was immunized with MBSA in CFA and challenged
with MBSA [22–24]. In the former reaction, a significant pro-
portion of endogenous migrating cells were eosinophils (20–
30%), and splenocytes cultured in the presence of specific
antigen produced significant amounts of IL-4, IL-5, IL-10, and
IFN-g, characterizing a Th0/2 phenotype. It is unclear whether
the production of IFN-g, in addition to Th2-type cytokines, by
SEA-activated lymphocytes is important for the eosinophil
migration observed or just represents the great ability of par-
asite antigens to stimulate the immune system. However, these
results are in marked agreement with inflammatory reactions
induced in other tissues by a similar immunization and chal-
lenge procedure [24, 30]. In the MBSA-induced, DTH reaction,
a marked inflammatory infiltrate characterized by the infiltra-
Fig. 7. Effects of the pretreatment with
anti-IL-4 or anti-IFN-g antibodies on
the recruitment of 111In-eosinophils in
Th1- and Th2-predominant, DTH reac-
tions. Control animals (open bars) and
animals that were immunized with (a)
MBSA/FCA (Th1) or (b) S. mansoni eggs
(Th2) were pretreated with anti-IL-4
(closed bars) or anti-IFN-g (hatched
bars) mAbs just prior to the challenge.
Skin sites were challenged i.d. with an-
tigen (MBSA, 10 mg/site; SEA, 1 mg/
site, respectively) 20 h before the i.v.
administration of 111In-eosinophils. The effects of the i.d. injection of PBS and
(c) LTB4 (150 pmol/site) immediately before the i.v. administration of
111In-
eosinophils into control and antibody-treated animals are shown for compari-
son. The number of 111In-eosinophils that migrated to skin sites was assessed
4 h after their i.v. administration. Results are the mean 6 SE of six animals in
each group. *p , 0.05, and **P , 0.01 when compared with control animals.
Fig. 8. Effects of the local pretreatment with anti-eotaxin antibody on the
recruitment of 111In-eosinophils in Th1- and Th2-predominant, DTH reactions.
Animals that had been immunized with MBSA/FCA (Th1) or S. mansoni eggs
(Th2) were challenged i.d. with antigen (MBSA, 10 mg/site; SEA, 1 mg/site,
respectively) 20 h before the i.v. administration of 111In-eosinophils. Control,
pre-immune serum (20% dilution in saline, open bars) or anti-eotaxin poly-
clonal antibody (20% dilution in saline, closed bars) was injected i.d. just prior
to the i.v. administration of 111In-eosinophils. The number of 111In-eosinophils
that migrated to skin sites was assessed 4 h after their i.v. administration.
Results are the mean 6 SE of seven–eight animals in each group. *p , 0.05
when compared with sites treated with control serum.
Fig. 9. Number of total cells and mature eosinophils in bone marrow obtained
from naı̈ve animals or animals immunized with MBSA/FCA or S. mansoni eggs.
Left femurs were obtained from naı̈ve mice or mice that had been immunized
with MBSA/FCA or S. mansoni eggs six days before the experiment and prior
to challenge. Bone marrows were flushed with RPMI as described in Materials
and Methods, and the number of (a) total leukocytes and (b) mature eosinophils
was evaluated. Results are the mean 6 SE of five animals in each group. *p ,
0.05 when compared with control.
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tion of mononuclear cells was observed, and very rare eosino-
phils or neutrophils were seen throughout the lesions at 24 h.
Splenocytes from these animals produced a significant amount
of IFN-g spontaneously, and this was increased in response to
specific antigen.
In contrast to the findings for endogenous eosinophils de-
scribed above, 111In-eosinophils migrated into sites of MBSA/
FCA, delayed-onset, hypersensitivity reactions in an antigen-
and CD4-dependent manner. Similarly, in animals immunized
with S. mansoni eggs and challenged with SEA, 111In-eosi-
nophils were also recruited in an antigen- and CD4-dependent
manner. Depletion of CD81 cells was not accompanied by any
significant change of 111In-eosinophil migration. These data
are in good agreement with other studies demonstrating a
fundamental role for CD41 T cells in the control of eosinophil
migration in sites of late-onset, allergic inflammation [18, 31,
32] and demonstrate that, when present in sufficient amounts
in blood, eosinophils derived from IL-5-transgenic animals
migrate to sites of both Th1 and Th2-predominant reactions.
The challenge of S. mansoni, egg-immunized animals with
SEA induced the local expression of IL-4 mRNA. In agreement
with this finding, pretreatment of these animals with anti-IL-4
mAb was accompanied by a significant inhibition of 111In-
eosinophil recruitment after challenge. In contrast, little IFN-g
was expressed after i.d. challenge with SEA, and treatment
with anti-IFN-g mAb had little effect on 111In-eosinophil mi-
gration. A central role for IL-4 in mediating eosinophil influx
into the lung or skin in Th2-predominant, allergic inflammation
has also been described previously [33, 34]. In MBSA/FCA-
immunized animals, there was a significant expression of
IFN-g early in the course of the reaction, and treatment with
anti-IFN-g mAb abrogated 111In-eosinophil recruitment into
skin sites of challenged animals. Moreover, pretreatment with
anti-IL-4 also abrogated 111In-eosinophil recruitment in
MBSA/FCA animals challenged with specific antigen. This was
an unexpected finding, inasmuch as splenocytes from these
animals produced little IL-4 upon stimulation with specific
antigen, and previous studies have demonstrated the depen-
dence of this Th1-predominant reaction on IL-12 production
[23]. Nevertheless, it is worth noting that, albeit in low levels,
IL-4 mRNA was detected following challenge of immunized
animals with MBSA. Furthermore, a role for IL-4 in mediating
eosinophil influx in sites of contact hypersensitivity reactions
has been described previously [35]. Overall, these studies
argue for an essential role for IL-4 in mediating eosinophil
recruitment following antigen challenge in cutaneous hyper-
sensitivity reactions. Moreover, they imply that mechanisms, in
addition to the local expression of IL-4, drive the specific
recruitment of endogenous eosinophils observed in both hyper-
sensitivity reactions. The means by which IL-4 drives eosino-
phil recruitment in our model has not been investigated in
detail. Nevertheless, our previous studies suggest that the
modulation by IL-4 of the expression of very late antigen
(VLA)-4 ligands, such as vascular cell adhesion molecule 1
(VCAM-1), may underlie the ability of this cytokine to regulate
eosinophil recruitment in mouse skin [22]. Alternatively, IL-4
may be driving the local production of eosinophil chemoattrac-
tants, specially eotaxin [17, 36, 37], by skin cells (e.g., fibro-
blasts), which may then drive local eosinophil recruitment.
We and others have demonstrated previously the important
role of the chemokine eotaxin for the recruitment of eosinophils
into sites of allergic inflammation in vivo [21, 38–40]. Here, we
show that eotaxin mRNA is expressed in late-onset hypersen-
sitivity reactions and, more importantly, that an anti-eotaxin
polyclonal antibody partially inhibits eosinophil recruitment
when administered just prior to antigen challenge. These ex-
periments are in agreement with previous studies demonstrat-
ing the expression of eotaxin by Th1 and Th2 lymphocytes [41].
Overall, these results argue that the local expression of the
chemokine eotaxin cannot explain the differential recruitment
of endogenous eosinophils observed in MBSA/FCA- and S.
mansoni-immunized and -challenged mice.
Next, we investigated whether the availability of mature
eosinophils in bone marrow and blood could provide an
explanation for the specificity of the migration of endoge-
nous eosinophils to sites of Th2-, but not Th1-predomi-
nant, DTH reactions. Our results clearly show that, in mice
immunized with S. mansoni eggs, there is an increase in the
number of eosinophils in the bone marrow. In contrast, in
MBSA/FCA-immunized mice, neutrophil, but not eosino-
phil, numbers increased. These results demonstrate a cor-
relation between availability of eosinophils in bone marrow
and the ability of endogenous eosinophils to migrate into
sites of DTH reactions. When exogenous, IL-5-derived eo-
sinophils are added, these cells are readily available for
migration in vivo. In support of this hypotheses, Nagai et al.
[42] have shown previously that the overproduction of IL-5
enhanced eosinophil migration in a model of dinitrofluoro-
benzene-induced contact hypersensitivity. Together, these
results corroborate the idea that the bone marrow may play
an active role in the recruitment of eosinophils in vivo [43].
In conclusion, we demonstrate the ability of exogenously
added, IL-5-primed eosinophils to migrate into sites of late
onset Th1- or Th2-predominant reactions in vivo. Exogenous
eosinophil migration was CD41 T cell- and IL-4-dependent
and partially blocked by an anti-eotaxin antibody. Neverthe-
less, endogenous eosinophils only migrated when found in
increased numbers in the bone marrow [present data; 42],
suggesting an important role for the bone marrow in controlling
eosinophil migration in vivo. Strategies aimed at modulating
eosinophil production and/or release from the bone marrow
may be of benefit in the therapy of eosinophil-associated dis-
eases, such as asthma and atopic dermatitis.
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